Nymox Pharmaceutical(NYMXF)
$0.020.00 (0.00%)
NYMXF
Nymox Pharmaceutical financials statements
$0.02
At close:0.00 (0.00%)
Want to see NYMXF full AI Analyst Report?
Nymox Pharmaceutical (NYMXF) Financial Statements
145 Followers
Nymox Pharmaceutical Financial Overview
Nymox Pharmaceutical's market cap is currently $2.10M. The company's EPS TTM is $-0.01; its P/E ratio is -0.45; Nymox Pharmaceutical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.00K | $ -1.00K | $ -11.00K | $ -12.00K | $ -12.00K |
| Operating Income | $ -3.68M | $ -4.28M | $ -8.35M | $ -6.65M | $ -12.50M |
| EBITDA | $ -3.56M | $ -4.26M | $ -8.77M | $ -6.52M | $ -12.49M |
| Net Income | $ -4.28M | $ -4.49M | $ -8.84M | $ -6.58M | $ -12.54M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.00K | $ 74.00K | $ 70.00K | $ 1.40M | $ 830.00K |
| Total Assets | $ 576.00K | $ 654.00K | $ 627.00K | $ 1.63M | $ 2.03M |
| Total Debt | $ 0.00 | $ 0.00 | $ 750.00K | $ 173.00K | $ 391.00K |
| Net Debt | $ -6.00K | $ -74.00K | $ 680.00K | $ -1.23M | $ -439.00K |
| Total Liabilities | $ 9.88M | $ 7.43M | $ 3.80M | $ 2.11M | $ 1.95M |
| Stockholders' Equity | $ -9.30M | $ -6.78M | $ -3.17M | $ -482.00K | $ 83.00K |
| Cash Flow | |||||
| Free Cash Flow | $ -1.81M | $ -2.60M | $ -4.06M | $ -5.21M | $ -9.83M |
| Operating Cash Flow | $ -1.81M | $ -2.60M | $ -4.06M | $ -5.21M | $ -9.82M |
| Investing Cash Flow | $ -1.00K | $ 0.00 | $ -3.00K | $ 0.00 | $ -6.00K |
| Financing Cash Flow | $ 1.74M | $ 2.60M | $ 2.73M | $ 5.78M | $ 7.04M |
Currency in USD
